Citation Formats
UPLC-Q-TOF/MS based untargeted metabolite and lipid analysis on premature ovarian insufficiency plasma samples
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. Taşcı Et Al. , "UPLC-Q-TOF/MS based untargeted metabolite and lipid analysis on premature ovarian insufficiency plasma samples," Current Pharmaceutical Analysis , vol.17, no.4, pp.474-483, 2021

Taşcı, Y. Et Al. 2021. UPLC-Q-TOF/MS based untargeted metabolite and lipid analysis on premature ovarian insufficiency plasma samples. Current Pharmaceutical Analysis , vol.17, no.4 , 474-483.

Taşcı, Y., Fındık, R. B., Pekcan, M. K., KAPLAN, O., & ÇELEBİER, M., (2021). UPLC-Q-TOF/MS based untargeted metabolite and lipid analysis on premature ovarian insufficiency plasma samples. Current Pharmaceutical Analysis , vol.17, no.4, 474-483.

Taşcı, YASEMİN Et Al. "UPLC-Q-TOF/MS based untargeted metabolite and lipid analysis on premature ovarian insufficiency plasma samples," Current Pharmaceutical Analysis , vol.17, no.4, 474-483, 2021

Taşcı, YASEMİN Et Al. "UPLC-Q-TOF/MS based untargeted metabolite and lipid analysis on premature ovarian insufficiency plasma samples." Current Pharmaceutical Analysis , vol.17, no.4, pp.474-483, 2021

Taşcı, Y. Et Al. (2021) . "UPLC-Q-TOF/MS based untargeted metabolite and lipid analysis on premature ovarian insufficiency plasma samples." Current Pharmaceutical Analysis , vol.17, no.4, pp.474-483.

@article{article, author={YASEMİN TAŞCI Et Al. }, title={UPLC-Q-TOF/MS based untargeted metabolite and lipid analysis on premature ovarian insufficiency plasma samples}, journal={Current Pharmaceutical Analysis}, year=2021, pages={474-483} }